Influence of percutaneous local therapy for hepatocellular carcinoma on gastric function

Table 5 Clinical factors associated with decreases in the %normogastria after treatment using regression analysis

	Regression coefficient	95%CI		P value	Partial regression coefficient	95%CI		P value
Sex (M)	-10.77	-27.34	5.79	0.196	-11.58	-29.4	6.25	0.196
Age(yr)	1.05	0.07	2.04	0.037	0.73	-0.45	1.91	0.22
Ethanol (use)	20.6	3.75	37.46	0.018	13.99	-3.88	31.87	0.121
Tumor location (left lobe)	-12.26	-32.3	7.78	0.224	-11.83	-32.05	8.39	0.243
Tumor size (cm)	-5.78	-14.32	2.77	0.18	-6.6	-14.89	1.68	0.115
RFA (use)	-0.54	-23.04	21.96	0.962	-5.74	-27.61	16.13	0.598
Child-Pugh (score)	-4.52	-11.96	2.92	0.227	-8.05	-15.3	-0.8	0.031

Regression analysis was performed to examine the relationship between decreases in the percentage of normogastria (%normogastria) after treatment and the following factors: patient sex, patient age, ethanol injection, location of the treated hepatoma (right or left lobe), tumor size (diameter), use of radio frequency ablation (RFA), and the Child-Pugh score.